PREMIER brings together a world-leading multidisciplinary consortium of 25 public and private partners with a vast with expertise in (eco)toxicology, environmental chemistry, analytical chemistry, chemical risk assessment, environmental regulation of pharmaceuticals, exposure and effect modelling, In vitro test systems (UH), machine-learning and read across, software implementation, pharmacology, drug design, data gathering and assessment, database development, stakeholder processes, uncertainty analysis and project management.
Several of the partners within PREMIER layed a prominent role in the iPiE project (2015-2019) – the previous IMI project on the environmental risks of APIs –, enabling a smooth transfer of valuable knowledge, insights, tools, and experiences into the current PREMIER project.
RESEARCH INSTITUTIONS
University of York
Radboud University Nijmegen
Rijksinstituut voor Volksgezondheid en Milieu
Eidgenoessische Anstalt Fuer Wasserversorgung Abwasserreinigung Und Gewässerschutz
Istituto di Ricerche Farmacologiche Mario Negri
Leuphana Universitat Luneburg
University of Exeter
Helsingin Yliopisto
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM
University of Gothenburg
The European Medicines Agency
Teamit Research
ECOLOGIC INSTITUT gemeinnützige GmbH
Simomics Limited
ECT Oekotoxikologie GmbH
AstraZeneca AB Ltd.
Bayer Aktiengesellschaft
Merck Sharp & Dohme Corp
Bristol Myers Squibb Company
NOVARTIS Pharma AG
SANOFI-Aventis Recherche & Développement
SERVIER
Eli Lilly and Company Limited